Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

DHR · Danaher Corporation

$232.97 +1.07% Oct 26 close
Detected setup Trend Only · Setup Score 79/100

Stand aside — setup invalidated

Setup score 79, but distribution days reach 5 or more — stand aside until the condition resets.

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about DHR

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$DHR

Danaher Corporation

Danaher Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $164B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 2
$232.97 latest close
Market Structure
Trend structure: uptrend
Latest event: structure_shift (bullish)
Support 196.75–201.00 · 9 touches · strong
Inside 230.65–233.02 · 6 touches · strong
Support 226.03–228.38 · 5 touches · strong
Support 222.62–223.75 · 3 touches · moderate
Support 188.06–189.21 · 3 touches · moderate
Momentum Turn Watch
Bollinger Squeeze Bollinger band width (11.4%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Verdict · setup score 79/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 79, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$200$220$240AugSepOct$233

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.2 150-day MA > 200-day MA — MA150 $196.94 vs MA200 $201.19
  • Minervini 2. Quarterly EPS growth ≥ 25% — -5.8% QoQ
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -5.8% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 70
  • Weinstein Volume expansion above average — Volume ratio 0.74x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 150-day MA > 200-day MA.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
60 Neutral
Legend Score · rates the stock Neutral (60/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 70
  • Trend Template (25%) 75
  • Institutional Footprint (20%) 64
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 70: above-average strength. Trend template 6/8: passes the uptrend screen, structure intact. Institutional score 64: mild accumulation. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Normal technical setup

Next earnings Wednesday, October 21, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

Reported EPS 2.11 vs estimate 1.9359 · surprise +9.0%

DHR+1.07%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. DHR was +1.07 points vs XLV. +0.36 points vs SPY.

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+1.07% From the open+0.88% Range position71% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $232.97 +1.1% Oct 26 close
52W High $242.80 4.0% below high
Wks Since High 38w
Base Depth 33.1% 33.7% today
RS Rank 35 percentile of scan
SMA 50 $216.74
Avg Vol 4,236,872
Rel Vol (Oct 26) 0.74× 0.78× on up days
More stats
52W Low $160.93
Tight Wks 1
Base B2
SMA 200 $201.19
RS Line vs High -13.8%
RS Line Slope +2.9% ▲
Group Rank #21/66
ADR% 3.0%
ATR(14) $6.48 (2.8%)
Vol Pace (live) N/A
A/D Days 14A / 10D
A/D Rating A
VDU Bars 0/10 d
Power Trend 14d
Earnings past
Position in 52-week range 88thpercentile of the 52-week range
$160.93low
$242.80high

DHR Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for DHR.

Create Free Account

Technical Analysis Report Card

$DHR · $232.97 · as of 2026-10-26 · multi-factor read
94
/ 100
Technicals 94/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$216.74 ↑
100-day$204.87 ↑
200-day$201.19 ↑
Bullish (50 > 200)

RSI (14)

Reading62.0 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.558

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width87% · 11.4%
Squeeze — volatility compressing

Near the upper band — buyers in control. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.78 · Neutral
Rel volume0.74×
Pocket pivots · 10d1
5d vs 50d vol169%
Heavy vol up / down2 / 2

Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.

  • Pocket pivot 9 sessions ago — up-day volume beat every down day of the prior 10 sessions.
  • 2 heavy-volume up days vs 2 down in the last 20 sessions.

Support & Resistance

R · $242.8052-week high
Price · $232.97now
S · $211.18swing level
S · $199.29swing level
S · $188.06swing level

Fibonacci · Uptrend swing

23.6%$219.91
38.2%$208.64
50.0%$199.53
61.8%$190.42
78.6%$177.45

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for DHR — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about DHR
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (79/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 6 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid C Trend-template read: fails 150-day MA > 200-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $232.97, MA150 $196.94, MA200 $201.19
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $216.74, MA150 $196.94, MA200 $201.19
Failing evidence
1.2 150-day MA > 200-day MAMA150 $196.94 vs MA200 $201.19
2. Quarterly EPS growth ≥ 25%-5.8% QoQ
6/10 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
N: Near 52-week high or RS line new high4.0% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.78%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-5.8% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 70
2/8 checks
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $232.97 vs MA200 $201.19
Failing evidence
Volume expansion above averageVolume ratio 0.74x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $211.18
Volatility-unit sizing (1N ≈ 1% of equity)1N = $6.55 (2.81% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
zanger Avoid D Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $267.92-$279.56; trail the rest
Trail on the 10/20-day MA10-day MA $228.38 · 20-day MA $223.55 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyTrend Only is not one of Zanger's six
Not extended (≤5% above the breakout point)Data unavailable
3/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Reasonable price for the growth (P/E ≤ 35); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Price strength (RS ≥ 70)RS score 70 — Zweig buys strength, not bargains
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (2025 adv / 1725 dec) — participation expanding
Failing evidence
EPS growth above the market (≥15% QoQ)-5.8% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 46.1x — no PEG or forward P/E stored
3/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$232.97
Relative strengthRS 70
Failing evidence
Volume vs average0.74x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumBuilding the top of the box (4.0% from 52W high) — watch for a box breakout with volume expansion.

Passing evidence
Price$232.97
Relative strengthRS 70
Failing evidence
Volume vs average0.74x
Box top broken on heavy volumeNot confirmed
4/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$232.97
Relative strengthRS 70
Failing evidence
Volume vs average0.74x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
94RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -3 A
A: 12 D: 15 Net: -365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -6%
✗ Revenue growth ≥20% YoY +3%
✓ Gross margin ≥30% 59%
✗ ROE ≥17% 8%
✗ RS rating ≥80 (leadership) 70
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -4.0%

Method Playbook

Trade it like Livermore EXACT LEVELS · PRO
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

79 setup score
RS Score 70
Trend template 5/8
Why This Setup? D+W Confluence
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 35 — laggard
  • Clear of earnings — not met in -6 days — event risk
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.7× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 5/8
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $232.97 vs SMA150 $196.94 / SMA200 $201.19
SMA 150 above SMA 200 SMA150 $196.94 vs SMA200 $201.19
SMA 200 trending up Slope -0.63 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $216.74
Price above SMA 50 $232.97 vs SMA50 $216.74
30%+ above 52-week low +44.8% from $160.93
Within 25% of 52-week high -4.0% from $242.80
RS score above 70 RS 70

Fundamentals

52W Range
88%
Mkt Cap SEC
163.9B
EPS QoQ
-6%
Rev YoY
+3%
ROE
8%
Gross Margin
59%
D/E
0.35
EPS TTM
$5.05
P/E TTM
46.1x
Float
704M
Insider
No Buy

Company

Company profile
Danaher Corporation
DHR · NYSE · Health Technology · Medical Specialties

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
6/8
W. RS
73
W. Support
$160.93
W. Resist
$238.13
W. Patterns
Cup & Handle
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Record Volume)Oct 23: 70 (Record Volume)Oct 26: 55 (Wyckoff SOS)Oct 27: 79 (Trend Only)79
Oct 27
Trend Only ✓ Gate
79
Oct 26
Wyckoff SOS
55 0.0%
Oct 23
Record Volume ✓ Gate
70 +1.1%
Oct 23
Record Volume
55 +1.1%

Latest News

Headlines for DHR
Loading headlines…

Get the full picture on DHR

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial